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Abstract
Background: Tuberculosis (TB) remains a major health problem in Zambia, despite considerable efforts to control
and prevent it. With this study, we aim to understand how perceptions and cultural, social, economic, and
organisational factors influence TB patients’ pre-hospital delay and non-compliance with care provided by the
National Tuberculosis Programme (NTP).
Methods: A mixed methods study was conducted with 300 TB patients recruited at Kanyama clinic for structured
interviews. Thirty were followed-up for multiple in-depth interviews. Six focus group discussions were organised
and participant observation was conducted. Ten biomedical care providers, 10 traditional healers, and 10 faith
healers were interviewed. Factors associated with non-compliance (disruption of treatment > one week) were
assessed by applying logistic regression analyses; qualitative analysis was used to additionally assess factors
influencing pre-hospital delay and for triangulation of study findings.
Results: TB treatment non-compliance was low (10 %), no association of outcome with cultural or socio-economic
factors was found. Only patients’ time constraints and long distance to the clinic indicated a possible association
with a higher risk of non-compliance (OR 0.52; 95 % CI 0.25, 1.10, p = 0.086). Qualitative data showed that most TB
patients combined understandings of biomedical and traditional TB knowledge, used herbal, traditional and/or faith
healing, suffered from stigmatizing attitudes, experienced poverty and food shortages, and faced several organisational
obstacles while being on treatment. This led in some cases to pre-hospital delay or treatment non-compliance.
Conclusions: Mixed methods analysis demonstrated the importance of in-depth information ascertained by qualitative
approaches to understand how cultural, socio-economic and organisational factors are influencing patients’ pre-
hospital delay and treatment compliance. To strengthen the Zambian NTP, combating stigma is of utmost priority
coupled with programmes addressing poverty. Organisational barriers and co-operation between (private) clinics and
traditional/faith healers should be considered.
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Background
Tuberculosis (TB) is one of the major global health
problems causing morbidity and mortality worldwide
[1], with the highest death rates in sub-Saharan Africa
[2]. In Zambia, the estimated incidence of tuberculosis is
427/100.000; 61 % of TB patients are co-infected with
the human immunodeficiency virus (HIV), and multi-
drug resistant TB (MDR-TB) is found in 0.3 % of new
cases and in 8.1 % of retreatment cases [1].
In 1993, the World Health Organization (WHO)
responded to this severe public health threat by promot-
ing the Directly Observed Therapy (DOT) policy to
ensure patients’ compliance with their treatment [3].
However, DOT is often criticized for its paternalistic na-
ture, and its implementation by National TB Pro-
grammes (NTPs) is often complicated by socio-
economic factors [4]. Current public health approaches
to control TB infection often take into account the co-
prevalence of MDR-TB and HIV infections, pill burden,
long treatment intervals, overburdened TB control pro-
grammes, and generally also consider cultural and socio-
economic factors influencing health care seeking behav-
iour of TB patients [4–9]. Often, vulnerable populations
are afflicted as TB is closely related to issues of stigma,
(economic) inequality, and poverty [5]. Stigma often
leads to the discrimination or social exclusion of TB pa-
tients, negatively influencing their health care seeking
behaviour [10]. Poverty complicates access to health care
as people are unable to stop working or to pay for public
transport; and hunger aggravates side effects of TB treat-
ment. Moreover, children with TB are difficult to diag-
nose and are often under-represented in NTPs [11–14].
The worrisome situation in Zambia has triggered the
development of various TB strategies and public health
efforts [15, 16]. Despite a longstanding DOT and sensi-
tisation programmes, Zambia still struggles with opti-
mizing its NTP to avoid pre-hospital delay and
treatment non-compliance of TB patients. Most studies
reporting on the TB policy and care provision in Zambia
use quantitative methods [17–22], focus on HIV-TB co-
infection [19, 20, 23, 24], are located in rural Zambia
[19–21, 23–25], or do not take children with TB into
account [17–21, 24]. To the best of our knowledge no
study has been published focussing specifically on
pre-hospital delay and treatment non-compliance of TB
patients (including children) in urban Zambia using a
combination of qualitative and quantitative methods.
The first analysis of our TB patients’ Adherence and
Compliance (TBAC) study focused on TB-related stigma
in Lusaka, Zambia [10]; the current analysis aims to
investigate the influence of perceptions and cultural, so-
cial, economic, and organisational factors on TB patients’




The study took place at Kanyama clinic in the urban
township Kanyama in Lusaka, Zambia, from September
2013 to January 2014. Details on Kanyama (clinic) and
the tuberculosis programme have been reported else-
where in detail [10].
Mixed methods
We used a mixed methods approach and a sequential
explanatory model in which quantitative and qualitative
research techniques were given equal priority; highlight-
ing different aspects of the study. The mixed methods
approach allowed for triangulation of study findings.
Study population and collection of data
During four months, we conducted researcher-
administered structured interviews (each approxi-
mately 30 min) with 300 TB patients attending
Kanyama clinic for TB treatment. The sample size
allowed us to estimate nine parameters of treatment
compliance in a multivariate logistic regression, based
on a prevalence of patients lost-to-follow-up (LTFU)
of 30 % in a Zambian study [22] and the sample size
recommendations for a logistic regression analysis to
investigate predictors with a 95 % confidence interval
[26]. Patients who paused their treatment for one or
more weeks were considered non-compliant and those
who had abandoned treatment for two weeks or more
were additionally considered LTFU.
Subsequently, of those 300 patients, we randomly
followed-up on 30 patients for one to three in-depth
semi-structured interviews (one to two hours each) at
their homes. To enhance our understanding of the TB
programme and the social and cultural context, we con-
ducted in-depth interviews with ten TB health workers,
ten faith healers, and ten traditional healers located in
Kanyama using a convenience sample.
Additionally, we organised six focus group discussions
(FGDs). Through convenience sampling, we recruited 10
treatment supporters for the first FGD and for the other
five FGDs eight patients and two treatment supporters
each. We conducted participant observation at the clinic,
the TB department, patients’ homes/neighbourhoods,
clinics/homes of traditional healers, and during faith heal-
ing sessions in various Christian churches in Kanyama
district.
We designed a structured questionnaire to discuss
demographics, biomedical knowledge, treatment history,
treatment compliance, and TB-related difficulties. The
in-depth interviews elaborated on the questionnaire and
discussed sensitive or complex topics, such as stigma
and pre-hospital delay. Patients who had waited over
four weeks since the onset of symptoms prior to their
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initial hospital visit were considered to have a pre-
hospital delay [27]. The FGDs covered the topics (1)
challenges in the work of TB lay health workers; (2)
childhood TB-related difficulties; (3) TB-related strug-
gles; (4) stigma; (5) health care seeking; and (6) biomed-
ical knowledge about TB. We used techniques to evoke
discussions and make respondents comfortable to speak
their minds; such as word association games, ranking of
themes, and poster presentations. The semi-structured
in-depth interviews with TB health workers, traditional
and faith healers elaborated on TB care and their work-
related challenges.
Statistical outcomes, variables and analysis
We compared demographics and TB treatment-related
parameters of the in-depth study sample (N = 30) with
the larger study group of TB patients (N = 270). We used
the Fisher’s exact test for categorical data and the
Student t-tests for normally distributed continuous data.
To identify factors that could be associated with TB pa-
tients’ treatment non-compliance, we conducted logistic
regression analyses. We conducted analysis with IBM
SPSS statistics version 21.0 (IBM Corp, Armonk, NY).
Qualitative outcomes, thematic, and content analysis
Qualitative data was analysed to explain, contextualize
and interpret quantitative findings. For the in-depth
interviews and FGDs, we conducted thematic and
content analysis assisted by Qualitative Data Analysis
and Research Software (ATLAS.ti, 7th edition; Scientific
Software Development GmbH, Berlin, Germany). Tran-
scripts were screened multiple times, coded into meaning
units and categorized into broad themes [28]. Addition-
ally, we analysed context, meaning, and structures of iden-
tified codes and themes [29]. Some quotes of respondents
were used to illustrate the most important themes [10].
Results
Study group
Mean age of the study population (N = 300) was 33 years
(range 1–70 years), including 25 children and teenagers
under the age of 20. In total, 193 patients were male
(64 %); 179 (59.7 %) were in a relationship; 126 (42 %)
had attended seven years of state-funded primary school;
and 205 (68 %) were (self-)employed. Patients were on
average 11 weeks on treatment [range 1–52]; 86 (29 %)
relapsed, i.e. were diagnosed again with active TB after
TB treatment completion (some repeatedly); 274 (94 %)
had done Voluntary Counselling and Testing (VCT) for
HIV; and 147 (54 %) had a positive HIV status of which
101 (69 %) were on antiretroviral therapy (ART). For the
qualitative sample, six children/adolescents and 24
adults were in-depth interviewed with a mean age of
31 years [range 2–54]; of which 17 (57 %) were male.
Demographics and tuberculosis-related parameters of
the in-depth sample were similar between the in-depth
and quantitative sample (Table 1).
Statistics and TB treatment non-compliance
In total, 31 patients (10 %) had previously been non-
compliant, ranging from pausing treatment for a week
to completely abandoning treatment (LTFU). Patients
mentioned one or more of the following reasons: feeling
better (4 %), side effects (2 %), being physically and fi-
nancially unable to come to the clinic (2 %), inability to
buy food (1 %), drinking beer (1 %), or having switched
to faith healing in a Christian church or herbal healing
(1 %). Overall, patients mentioned the use of alternative
health care, such as faith healing (36.6 %), self-
medication (22.7 %), and traditional healing (11.7 %),
and struggles with TB care, such as stigma (37.7 %), fi-
nancial constraints and hunger (34.3 %), and/or difficul-
ties with time constraints and/or long distances to be
covered to reach the clinic (46.3 %) (Fig. 1).
There was no evidence of an association between non-
compliance and sex, age, education, profession, HIV,
seeking alternative health care, stigma, or financial con-
straints (Table 2). Patients’ difficulties with time/distance
to be at/reach the clinic indicated a possible association
with a higher risk of non-compliance (OR 0.52; 95 % CI
0.25, 1.10, p = 0.086). The majority (76 %) came on foot
to the clinic (time ranged from five minutes up to two
hours depending on distance and ability to walk). Many
patients declared drug collection constraints with time
and distance to the clinic due to work, travel, domestic
responsibilities, financial hurdles, or physical inability
to walk.
TB perceptions
In total, 175 TB patients (58 %) explained they had no
previous biomedical knowledge before coming to the
clinic; and 198 (66 %) did not associate their symptoms
with TB beforehand. Forty-five patients got biomedical
TB information at school (15 %), 180 from friends or
family (60 %), and/or 201 at the clinic (67 %). In total,
99 patients (33 %) said they had not received any infor-
mation at the clinic. Some explained that they had been
too tired for the sensitisation talks of the TB health
workers or that the information was too difficult to
comprehend.
A majority of 293 patients (98 %) was able to mention
one or more of the four main TB symptoms highlighted
in the clinic’s sensitisation brochure: coughing, night
sweats, loss of appetite/weight, and chest pain. When
asked about the consequences of interrupted or incor-
rect drug intake, 51 patients (17 %) had no idea; 79
(26 %) mentioned resistance to TB drugs, and 170
(57 %) referred to death, injections, restart of treatment,
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and/or falling ill, but were generally unsure about the
reason why this would happen. The biomedical aetiology
of TB was known by 286 patients (95 %) who mentioned
its airborne nature and/or coughing. Some patients used
biomedical terms, but after probing they did not fully
comprehend the meaning. Moreover, 270 patients (90 %)
combined biomedical explanations (cough/airborne)
with one or more alternative aetiological principles. A
considerable group of patients stated that TB could be
contracted by sharing a cup or plate with a TB patient
(52 %) or that TB could (also) be caused by evil spirits
or witchcraft (28 %). Some respondents claimed that TB
was a genetic disease (family TB), a disease caused by
God or fallen angels, or by immoral behaviour, such as
drinking beer, smoking, promiscuity and prostitution
(Table 3).
During in-depth interviews and FGDs, various respon-
dents explained that coughs in general, and TB more
Table 1 Patient characteristics (300 TB patients), comparison quantitative sample N = 270 with in-depth sample N = 30, Lusaka, Zambia






P-valuea OR (95 % CI)b
N (%)c N (%) N (%)
Age (years)
Mean [SD] 33.3 [11.3] 33.6 [11.1] 31.0 [13.3] 0.240 (−6.85, 1.72)
Sex
Male 193 (64.3) 176 (65.2) 17 (56.7) 0.422 1.43 (0.67, 3.08)
Female 107 (35.7) 94 (34.8) 13 (43.3)
Marital status
Married/relation 179 (59.7) 165 (61.1) 14 (46.7) 0.169 1.80 (0.84, 3.83)
Single 121 (40.3) 105 (38.9) 16 (53.3)
Education
Low (none-7 years) 148 (49.3) 136 (50.4) 12 (40.0) 0.337 1.52 (0.71, 3.28)
High (7 yrs-higher) 152 (50.7) 134 (49.5) 18 (60.0)
Profession
Employed 205 (68.3) 187 (69.3) 18 (60.0) 0.307 1.50 (0.69, 3.26)
Unemployed 95 (31.7) 83 (30.7) 12 (40.0)
Treatment duration (wks)
Mean [SD] 10.8 [8.3] 10.9 [8.3] 9.5 [9.0] 0.368 (−4.60, 1.71)
TB Relapse
Yes 86 (29.0) 77 (28.8) 9 (30.0) 1.000 1.06 (0.46, 2.41)
No 211 (71.0) 190 (71.2) 21 (70.0)
Unknown 3 (1.0) 3 (1.1) 0 (0.0)
VCT
VCT 274 (94.2) 247 (94.3) 27 (93.1) 0.681 1.22 (0.27, 5.62)
No VCT 17 (5.8) 15 (5.7) 2 (6.9)
Unknown 9 (3.0) 8 (3.0) 1 (3.3)
HIV
HIV positive 147 (53.8) 130 (52.8) 17 (63.0) 0.417 0.66 (0.29, 1.50)
HIV negative 126 (46.2) 116 (47.2) 10 (37.0)
Unknown 27 (9.0) 24 (8.9) 3 (10.0)
HIV patients on ART
ART 101 (68.7) 86 (66.2) 15 (88.2) 0.094 0.26 (0.06, 1.19)
No ART 46 (31.3) 44 (33.8) 2 (11.8)
Unknown/not applicable 153 (51.0) 140 (51.9) 13 (43.3)
aFisher’s Exact Test for categorical variables, t-test for continuous variables comparing quantitative and in-depth sample
bOR (95 % CI) Odds Ratio and 95 % Confidence Interval
cValid percent
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specifically, could be explained with the local term
traditional myths. According to such myths, a cough
was caused by eating food that had been salted by a
menstruating woman or a woman who had just
aborted; or when having sexual intercourse with a
menstruating woman or a woman who had just
aborted. In the latter case, the spirit of an aborted
embryo (Kapopo) caused the cough. Some respon-
dents also mentioned that babies with a cough are
suspected to have been tyoled – a locally used term
indicating that their father had been unfaithful and
touched the baby in the first week after birth.
When asking about the links between traditional
coughs and TB, responses varied. Some patients denied
any linkage:
I don’t believe you can get TB according to this myth
about abortion or menses, but you can get Chantanda
wanga [a cough] if you do that. The kapopo [aborted
embryo] comes to you, just like that, but it is not TB
(in-depth interview 52-year old male TB patient).
Most traditional healers and several TB patients made a
distinction between heavy, deep coughs that can be ex-
plained by a traditional myth, versus normal coughs caused
by TB. Health workers said that some patients didn’t be-
lieve their cough was related to TB. This disbelief was even
more prevalent in case of children, because many people
explained that children were unable to get TB and that
their cough had to be caused by witchcraft or by being
tyoled. Some patients attributed both myths and biomed-
ical aetiologies to TB infection combining the information
of clinical staff with the local knowledge about traditional
myths. Some patients explained that any cough, and there-
fore also the traditional coughs could indicate TB infection.
Health workers shared this message during community
sensitisation programmes. Various patients were uncertain
about the relation between traditional coughs and TB.
Cultural factors
In total, 154 patients (51.3 %) reported concurrent use
of biomedical health care provision, such as traditional,





























Fig. 1 TB-related struggles and alternatives for biomedical TB care of 300 TB patients, Lusaka, Zambia. Numbers do not add up to 300, because
the questions allowed for multiple responses





P-value OR (95 % CI) b
N (%) c N (%) c
Sex (male) 169 (63.3) 24 (72.7) 0.230 0.60 (0.26, 1.39)
Age (>31 yearsd) 151 (56.1) 16 (51.6) 0.632 1.20 (0.57, 2.52)
Level of education (none - primary school) 133 (49.8) 15 (45.5) 0.624 0.83 (0.39, 1.75)
Profession (employed) 179 (67.0) 26 (78.8) 0.255 0.60 (0.25, 1.45)
HIV (HIV +) 129 (53.3) 18 (58.1) 0.586 1.24 (0.57, 2.71)
Seeking alternative health care (yes) 138 (51.7) 16 (48.5) 0.729 1.14 (0.54, 2.40)
Stigma (yes) 101 (82.1) 12 (80.0) 0.841 0.87 (0.23, 3.35)
Financial constraints (yes) 89 (33.3) 14 (42.4) 0.348 0.70 (0.33, 1.48)
Difficulties with time/distance to be at/reach the clinic (yes) 104 (39.0) 17 (51.5) 0.086 0.52 (0.25, 1.10)
aPatients who had previously paused their treatment for one or more weeks or had abandoned treatment were considered non-compliant
bOR (95 % CI): Odds Ratio and 95 % Confidence Interval
cValid percent
dIn both age groups same percentage of non-compliant patients
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respondents explained that many community members
did not start with a clinic visit, but rather used locally
available herbal treatments in Kanyama to treat their
cough. Generally, the second step was going to a market
or Kantemba, a cheap unlicensed pharmacy.
During FGDs, participants explained that the majority
of Zambians generally used traditional healing for
treating illness, yet seldom for TB. This idea was slightly
nuanced during in-depth interviews where often a differ-
ence was made between traditional healers in the city
and in the village, making some of them travel to rural
areas for TB care:
For TB I don’t like African herbs or pastors. Many
people have died. […] Traditional healers steal your
money. Only some will know everything, if you are
bewitched and by whom. But nowadays many doctors
just make it up. The real traditional healers from the
village can heal TB, but they’re few (in-depth interview,
28-year old male TB patient).
Some respondents had initially started with faith heal-
ing. Respondents favouring faith healing often said that
TB resulting from evil spirits could only be healed by
faith healing and not in the clinic.
At church, people say spirits bring disease. A demon
for TB, a demon for HIV. If you pray, you get healed.
I also believe in that. But for my daughter it is not a
demon, because deliverance [exorcism of disease-
bringing spirit] didn’t help. Then we went to the clinic
(in-depth interview 33-year old mother of nine
year-old TB patient).
During in-depth interviews and one FGD, patients
mentioned reasons for not first attending Kanyama
clinic when falling ill, such as the idea they had a general
cough; that TB was caused by non-biomedical causes;
advice of their pastor or family member; or advantages
from attending alternative care providers such as ab-
sence of long queues, quick patient service, guaranteed
anonymity, and easier accessibility. Some patients and
biomedical staff explained that traditional healers and
faith healers could cause substantial pre-hospital delays.
Social factors
During structured interviews, 113 TB patients (35 %)
mentioned they suffered from loss of self-esteem, shame,
Table 3 Biomedical TB knowledge reported by 300 TB patients






night sweats, loss of
appetite, chest pain
no symptoms of TB 7 (2.3)
two or three symptoms of TB 207 (69.0)
four symptoms of TB 86 (28.7)
Treatment compliance and multi-drug resistant TB
Respondents who did not know the importance
of treatment compliance
51 (17.0)
knew the importance of
treatment compliance
170 (56.7)
knew the importance of
treatment compliance and








sharing cups, utensils 155 (51.7)
evil spirits/witchcraft 85 (28.3)
traditional myths 58 (19.3)
smoking 50 (16.7)
drinking beer 39 (13.0)
promiscuous behaviour 38 (12.7)
prostitution 32 (10.7)
god 28 (9.3)
genetic disease (Family TB) 11 (3.7)
aNumbers do not add up to 300, because the questions allowed for
multiple responses
Table 4 Alternative healing methods for tuberculosis in Urban Zambia assessed both during researcher-administered structured
interviews, in-depth interviews with TB patients, traditional and faith healers, and FGDs at Kanyama clinic
Healing methods Medication or practices
Self-medication - herbal Lemons, ginger, garlic, beetroot, leaves of: the banana plant, the Moringa, Nim, Blue Gum eucalyptus,
guava, or mango tree, aloe Vera
Self-medication - Katemba / markets Panadol, cough syrup, Chinese medicine, Back-to-Eden-herbs
Faith healing Prayer, deliverance (exorcism of evil spirit), fasting and praying on a sacred mountain, holy water
and/or anointed oil, Back-to-Eden-herbs, faith
Traditional healing - herbal Traditional herbs, such as Nkonka, Muleza (also named Kankalamba or Munsokansoka), Mutato
(herbal energy booster)
Traditional healing - spiritual Witchcraft (mfuiti), consulting the spirits/ancestors, sacrificing small animals
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insulting remarks, ridicule, discrimination, divorce,
dismissal at work, and/or social isolation. Yet during
in-depths interviews at home, more than half of the
patients (60 %) elaborated on the consequences of
stigmatizing neighbours and friends.
I had TB before, and my neighbours said to their
children: don’t go in that house! They never come near
me, only greet me from far away. They are afraid of
getting TB. They will say: that is not a normal cough.
That is TB. He has Kanayaka (in-depth interview
24-year female TB patient).
During the FGD on TB-related stigma, both patients
and TB health workers explained to me that the local de-
rogatory term for people with HIV, kanayaka – literally,
“the red light that does not switch off” – is often used to
label TB patients. The label kanayaka signalled to others
that TB patients were infectious and therefore dangerous,
and that their lives would soon come to an end. Because
of the label many TB patients explained that they add-
itionally dealt with HIV-associated negative stereotyping,
being accused of immoral behaviour, promiscuity, alcohol-
ism, chain-smoking, and prostitution.
The FGDs also provided insight in the relation be-
tween stigmatization and a denial of a positive TB diag-
nosis, non-disclosure, and/or difficulties with initial
hospital visit and treatment compliance. Fearful of a
positive diagnosis and associated stigmatizing reactions,
some people rejected testing:
One of my cousins [a household member] died of
TB, because she didn’t want to go to the clinic and
didn’t want treatment. I have tested myself and my
grandson. The rest of the household doesn’t want to
do a test for TB or HIV, because they are afraid
for the test results. They say they can’t have TB
(interview 65-year old grandmother of 1-year old
child on preventive TB treatment).
Respondents explained that women were sometimes
forcibly expelled to the village to hide their TB diagnosis
and treatment from neighbours. (No answer was given
to why this did not happen for men.) During one
in-depth interview, a TB patient described that she was
send away and that in rural areas TB treatment was not
easily accessible or available. This contributed to her
treatment disruption and aggravation of TB. She had
almost died and came back to the city to attend
Kanyama clinic and retake TB treatment.
Economic factors
Quantitative data showed that 103 patients (34 %) faced
serious food shortages.
In Zambia the problem is mostly food. You eat once a
day, it is not even good. Especially with TB drugs, it is
hard, every day we have to take drugs. It makes you
hungry, dizzy, shaky, but I have no food, no money
(interview 37-year old male TB patient).
The in-depth interviews provided insight into the
intersection of poverty and treatment compliance. Pa-
tients explained that the “strong medication” made them
feel hungry and weak. Hunger complicated coping with
side effects and treatment compliance. Some patients
filled their stomach with cheap maize opaque beer
(Chibuku), generally not realising that alcohol can ren-
der TB medications less effective. Patients explained that
alcohol was also a way to free their minds of (financial)
problems.
During in-depth interviews, health care workers and
various patients indicated delays in search for TB care at
the clinic, because poverty forced many patients to con-
tinue working and the majority had no health insurance.
136 patients (45.3 %) were in a severe health condition
on first arrival at the clinic. Few patients were financially
supported by their family-members, employers, or
landlords.
Organisational factors
Participant observation and informal conversations with
both the TB health workers and the patients provided
insight into the efforts of the understaffed TB team
regarding provision of patient service, medication distri-
bution, and record-keeping at the TB department of
Kanyama clinic. The voluntary treatment supporters
seemed an indispensable asset enhancing contact be-
tween TB patients and the clinic and sensitizing the
community about TB infection. Moreover, the nurses ex-
plained that in the past the clinic had contacted several
faith healers and three private clinics in Kanyama district
in order to enhance hospital referral of TB patients, and
to supply the latter with correct TB drugs. The Kanyama
clinic worked with a strict TB drug collection schedule
based on the stage of treatment patients were involved
in. Consequently, family members in different treatment
stages were required to individually collect medication
on different days.
Participant observation showed that patients simultan-
eously diagnosed with TB and HIV received additional
care at the clinic (different medication, support groups);
however, three HIV patients who started TB treatment
at a later stage went unnoticed by health workers,
leading to a mismatch of TB and HIV drugs. Other or-
ganisational problems regarding administration of TB
patients occurred when patients moved to the rural area
and were transferred to a local clinic. These patients
were invariably LTFU.
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Discussion
In this study, we examined perceptions and cultural,
social, economic, and organisational factors influencing
TB patients’ pre-hospital delay and compliance to care
provided by the NTP using a mixed methods research
approach. Quantitative data analysis showed no associ-
ation between treatment compliance and demographic
characteristics, patients’ TB-related struggles, or alterna-
tive health care seeking. In contrast, qualitative data
identified how TB perceptions, stigma, poverty, and
organisational obstacles influenced TB patients’ pre-
hospital delay and treatment non-compliance undermin-
ing an effective TB control programme.
TB perceptions
Quantitative findings illustrated that most TB patients
used both biomedical and traditional understandings of
TB knowledge. Qualitative findings provided insight that
many patients were unsure how to combine the variety
of TB perceptions available. Previous studies have shown
the importance of perceptions on health care seeking
behaviour [28–32] and have stressed the importance
of cultural-sensitive sensitisation programmes [7, 8,
33]. We propose interactive awareness programmes
that acknowledge and appropriately address the var-
iety of local perceptions to enhance early case-finding
and reduce hospital delay. Furthermore, patients’
usage of traditional healers, faith healers, and private
clinics calls for a collaborative strategy between clinics
and these alternative healers, as promoted by the
WHO [34] and proven effective according to various
studies in sub-Saharan Africa [35–38].
Stigma
Quantitative analysis showed a high prevalence of stig-
matising attitudes and actions by patients’ community
and family members, as we have previously reported in
detail [10]. Stigmatizing perceptions were amongst
others represented by the locally-used derogatory term
Kanayaka, to label both TB and HIV patients. This
linkage seemed to aggravate TB patients’ experience of
stigma, targeting them additionally with HIV-related
accusations. This is in line with previous reports from
Zambia [3, 25]. Children were as vulnerable to stigma as
adults calling for more research focused on this age
group [10]. A high number of the stigmatised patients in
this study consisted of women, whose vulnerable
position in society was exacerbated by the use of local
traditional myths blaming women for the spread of TB
and HIV [3, 10]. TB programmes targeting stigma-
related perceptions and attitudes need further improve-
ment [10], specifically regarding patient support and family
sensitisation, which could be achieved through organisation
of support groups for TB patients irrespective of HIV
status. Moreover, the collaborative TB/HIV programme
should address the extra dimension of TB-related stigma
linked to HIV with renewed TB/HIV sensitisation pro-
grammes and pay particular attention to the vulnerable
position of children and women herein.
Poverty
Patients’ low socio-economic status was related to often
cited struggles of regular food shortages, resonating with
World Bank statistics [39] that 61 % of the Zambian
population lives below the poverty line. A case study
from Lusaka described poverty levels to be specifically
high in slum areas such as Kanyama [40]. In-depth inter-
views with health care staff and patients clarified that
almost none of the respondents had a private health
insurance. Consequently, patients often postponed an
initial clinic visit or (temporarily) discontinued treat-
ment to avoid loss of income. When falling seriously ill,
many patients faced (financial or physical) difficulties
attending the clinic, taking treatment, and/or deal with
adverse medication effects. TB often disrupted livelihoods
as cash income declined, especially when breadwin-
ners fell ill.
Participant observation showed that TB patients lived
in conditions with a high risk of TB infection due to
overcrowded housing and poor ventilation. The majority
of people in the community were too poor to reduce
these risks, and given high local crime rates, many
patients preferred closed doors and windows. Because
the TB programme is mainly focused on physical health
and not on improving living conditions, cured patients
can acquire TB again and again. Poverty is well known
to fuel tuberculosis and remains a major challenge to TB
control programmes worldwide, undermining the effect-
iveness of (free) TB drugs [5, 41–44]. Several Zambian
studies have described low socio-economic status to be
an obstacle to TB care referring to the necessity of food
aid and payment of transport costs for both TB and HIV
patients [21, 23, 45, 46]. About a decade ago, two
Zambian studies described successful Home Based Care
(HBC) organisations [47, 48] providing food aid, but due
to financial constraints these organisations ceased their
programmes. Based on our qualitative findings and the
literature, we advocate to not only diminish symptoms
of poverty with renewed HBC programmes, but to also
make an end to what may be considered structural
violence embedded within longstanding social and eco-
nomic structures of inequality [49]. The position of TB
patients and associated TB prevalence and incidence, can
only be improved if poverty is substantially alleviated.
Alcohol consumption was often mentioned by respon-
dents in relation to poverty. Sensitisation programmes
about alcohol’s destructive effects on TB treatment fall
short, ignoring the socio-economic context in which TB
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patients in our study sometimes depended on alcohol to
deal with hunger, (financial) problems, and to numb
themselves. Data from South Africa showed that poverty
alleviation reduced substance abuse among South African
TB patients and improved TB care [50].
Organisational obstacles
Difficulties with TB patients’ long time/distance to the
clinic’ indicated a trend with ‘treatment non-compliance’,
which could potentially relate to patients’ work-related
commitments making it difficult to (timely) collect
medication. The clinic should take time and distance
constraints into consideration permitting patients to
collect medication for a longer period of time and/or
for the whole household, eliminating long queues and
enhancing a direct flow to the TB department pos-
sibly preventing unnecessary deaths and in-hospital
transmission.
Furthermore, full integration of TB and HIV services fell
short in certain instances and is of utmost importance;
as recommended by the national TB control programme;
and as implemented in other sub-Saharan African
countries [51–53]. Moreover, inadequate communication
between Kanyama clinic and rural clinics hindered record
keeping of transferred patients and an accurate adminis-
tration and are in need of improvement.
Limitations and strengths
A limitation of this study was that pre-hospital delay
was only qualitatively and not quantitatively assessed,
because related structured interview questions triggered
vague or contradictory responses due to lack of time,
and inability of interviewees to remember in detail their
pre-hospital illness experience. In-depth interviews did
generate insights regarding pre-hospital delay, suggesting
future qualitative research on the topic. Furthermore, it
was impossible to add TB knowledge as a risk factor for
treatment compliance in the univariate analysis, because
of the time gap between previous non-compliant behav-
iour and current knowledge. Prospective studies are
needed assessing the impact of baseline TB knowledge
on treatment non-compliance.
The strengths of this study was the mixed method
design and sequential explanatory model. Triangulation
of research findings enabled iterative analysis. The
combination of methods was specifically valuable when
quantitative methods fell short and qualitative methods
could fill these information gaps.
Conclusions
Mixed methods analysis clearly demonstrated the import-
ance of qualitative approaches to understand how cultural,
social, economic and organisational factors are influencing
pre-hospital delay and treatment non-compliance with
regards to the Zambian NTP. Patients’ concurrent use of
local TB understandings and health care calls for cultural
sensitive TB education and co-operation between (private)
clinics and traditional/faith healers. To strengthen the
Kanyama clinic’s existing programmes, combating stigma
is of utmost priority coupled with programmes addressing
poverty. Organisational barriers regarding drug collection
schedules, patient transfers, and integrated HIV-TB
programme should be addressed.
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